|
參考文獻
Akaike, N., Furukawa, K., Kogure, K.1993. Rolipram enhances the development of
voltage-dependent Ca super(2+) current and serotonin-induced current in rat
pheochromocytoma cells. Brain. 620, 58-63.
Amara, S. G., and Kahar, M. J. 1993. Neurotransmitter transporters. Annu. Rev. Neurosic. 16, 73-93.
Arslan, G, et al., 2000. P2Y receptors contribute to ATP-induced increase in
intracellular calcium in differentiated but not undifferentiated PC12 cells.
Neuropharmacology, 39, 482-496.
Barnard,-E.A.; Simon,-J.; Webb,-T.E.1997. Nucleotide receptors in the nervous
system: An abundant component using diverse transduction mechanisms
Mol. Neurobiol. 15, 103-130.
Beckstead, R., Domesick, V.B., Navta, W. J. H. 1979. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175, 191-217.
Bencherif, M., Lovette, M.E., Fowler, K.W., Arrington, S., Reeves, L., Caldwell, W.S., Lippiello, P.M. 1996. RJR-2403: A nicotinic agonist with CNS selectivity I. In vitro characterization. J. Pharmacol. Exp. 279, 1413-1421.
Bradford, M. 1976. Arapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding. Anal.
Biochem. 72, 248-254.
Carboni, E., Imperato, A., Perezzani, L., Di-Chiara, G. 1989. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28, 653-661.
Castro, E., OSET-Gasque, M.J., Canadas, S., Gimenez, G., and Gonzalez, M. P. 1988.
GABAA and GABAB Sites in Bovine Adrenal Medulla Membranes. J. Neuro. Res. 20, 241-245.
Charest, R., Blackmore, P. F., and Exton, J. H. 1985. Characterization of responses of
isolated rat hepatocytes to ATP and ADP. J. Biol. Chem. 260, 15789-15797.
Connor, T. J., Kelly, J. P., Leonard, B. E. 2000. An assessment of the acute effects of
the serotonin releasers methylenedioxy-methamphetamine, methylenedioxy
-amphetamine and fenfluramine on immunity in rats. Immunopharmacology. 46, 223-235.
Criado, M., Alamo, L. and Navarro, A., 1992. Primary structure of an agonist binding
subunit of the nicotinic acetylcholine receptor from bovine adrenal chromaffin
cells. Neurochem. Res. 17, 281-287.
Duvoisin, R. M., Deneris, E. S., Patrick, J., and Heinemann, S. 1989. The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: beta 4. Neuro. 3(4): 487-496.
Eric, A., Barnard. 1992. Receptor classes and the transmitter-gated ion channels.
Trends in Biochemical Science. 17, 367-374.
Fallon, J. H., Koziell, D. A., Moore, R. Y. 1978. Catecholamine innervation of the
basal forebrain. II,III,IV. J. Comp. Neurol. 180, 509-532.
Fasolato, C., Pizzo, P., and Pozzan, T. 1990. Receptor-mediated calcium influx in
PC12 cells. J. Biol. Chem. 265, 20351-20355.
Fischer, J. F., and A. K. Cho. 1979. Chemical release of dopamine from striatal
homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp.
Ther. 208, 203-209.
Folk, G. E., J., Long, J.P. 1988. Serotonin as a neurotransmitter: A review.Comp.
Biochem. Physiol. 9 , 251-257.
Fung, Y. K., .Lau, Y. S. 1992. Chronic effects of nicotine on mesolimbic
dopaminergic system in rats. Pharmacol. Biochem. Behav. 41, 57-63.
Gallo, V., Pende, M., Scherer, S., Molne, M., Wright, P. 1995. Expression and
regulation of kainate and AMPA receptors in uncommitted and committed neural
progenitors. Neurochem.Res. 5, 549-560.
Gopalakrishnan, M., Molinari, E.J., Sullivan, J.P. 1997. Regulation of human alpha
4 beta 2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands
and second messenger pathways. Mol. Pharmacol. 52, 524-534.
Grynkiewicz, G., Poenie, M., and Tsien, R. Y. 1985. A new generation of Ca2+ inducators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
Hakki, A., Hallquist, N., Friedman, H., Pross, S. 2000. Differential impact of nicotine on cellular proliferation and cytokine production by LPS-stimulated murine splenocytes. Int. J. Immunopharmacol. 22, 403-410.
Henderson, L.P., Gdovin, M.J., Liu, ChunLei., Gardner, P.D. Maue, R. A. 1994.
Nerve growth factor increases nicotinic ACh receptor gene expression and
current density in wild-type and protein kinase A-deficient PC12 cells.
J. Neur osci. 14, 1153-1163.
Hoffman, A. F., and Gerhardt, G. A. 1998. In vivo electrochemical studies of
dopamine clearance in the rat substantia nigra: （net transporter nom）Effects of
locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions. J.
Neurochem. 70, 179-189.
Huang, C. M., and Kao, L. S. 1996. Nerve growth factor, epidermal growth factor,
and insulin differentially potentiate ATP-induced [Ca2+]irise and dopamine
secretion in PC12 cells. J. Neurochem. 66, 124-130.
Johnson, R. G. 1988. Accumulation of biological amines into chromaffin granules: a model for horomone and neurotransmitter transporter. Physiol. Rev. 68, 232-307.
King, B. F., Ziganshina, L. E., Pintor, J., and Burnstock, G. 1996. Full sensitivity of
P2X2 purinoceptor to ATP revealed by changing extracellular Ph. Bu. J.
Pharmacol. 117, 1371-1373.
Liang, N. Y., and Rutledge, C. O. 1982. Comparison of the release of [3H] dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlavelled dopamine. Biochem. Pharmacol. 31, 983-992.
Liu, P. S., Lin, Y. J., and Kao, L. S. 1995. Effects of caffeine on Ca2+ fluxes and
secretion in bovine chromaffin cells. Eur. J. Pharmacol. 291, 265-272.
McEvoy, G. K. 1986. Drug information. The Merck index 10th Edition. p852.
Milner, T.A., Joh, T.H., Pickel, V.M. 1986. Tyrosine hydroxylase in the rat parabrachial region: Ultrastructural localization and extrinsic sources of immunoreactivity. J. Neurosic. 6, 2585-2603.
Miyamoto, J.K., Uezu, E., Jiang, P. J., Miyamoto, A.T. 1993. H super(+)-ATPase and transport of DOPAC, HVA, and 5-HIAA in monoamine neurons. Physiol. Behav. 53, 65-74.
Moore, R. Y., Bloom, F. E. 1979. Central catecholamine neuron system: anatomy and
physiology of the norepinephrine and epinephrine system. Annu.Rev. Neurosci.
2, 118-168.
Morita , S. M., Dohi , T., and Tsujimoto ,A., 1990. GABAergic modulation of
catecholamine release from cultured bovine adrenal chromaffin cells. Evidence
for the involvement of Cl－-dependent Ca2+ entry. Naunyn-Schmiedeberg’s Arch
Pharmacol. 341, 419-424.
Peter, D., Jimenez, J., Liu, Yongjian., Kim, J., and Edwards, R.H. 1994. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269, 7231-7237.
Roehm, N. W., Rodgers, G. H., Hatfield, S. M., and Glasebrook, A. L. 1991. An
improved colorimetric assay for cell proliferation and viability utilizing the
tetrazolium salt XTT. J. Immunol. Methods. 142, 257-265.
Schuller, H. M. 1997. Neurotransmitter receptors and lung cancer. Symposium on
Mechanisms of Toxicity, np, 8-10.
Seiden, L.S., Sabol, K.E., Ricaurte, G. A. 1993. Amphetamine: Effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33, 639-677.
Silinsky, E. M., and Ginsborg, B. L. 1983. Inhibition of acetylcholine release from
preganglionic frog nerves by ATP but not adenosine. Nature. 305, 327-328.
Skau, K. A., and Gerald, M. C. 1977. Amphetamine inhibition of alpha-bungarotoxin
binding at the mouse neuromuscular junction. Life Sci. 20, 1495-1499.
Smit, M. J., Leurs, R., Bloemers, M. S., Tertoolen, L. G., Bast, A., Laat, S. W., and
Timmerman, H. 1993. Extraellular ATP elevates cytoplasmatic free Ca2+ in
HeLa cells by the interaction with a 5’-nucleotide receptor. Eur. J. Pharmacol.
247, 223-226.
Snyder, S. H., S. P. Bnagerjee, H. I. Yamamura, and D. Dreenberg. 1974. Drugs, neurotransmitters, and schicophrenia. Science. 184, 1243-1253.
Spitzmaul, G.F., Esandi, M. del C. and Bouzat, C. 1999. Amphetamine acts as a
channel blocker of the acetylcholine receptor. Neuroreport 10, 2175-2181.
Warpman, U., Friberg, L.,Gillespie, A., Hellstroem-Lindahl, E., Zhang, Xiao.,
Ordberg, A. 1998. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells. J.
Neurochem. 70, 2028-2037.
Wilson, S. P. 1987. Purification of adrenal chromaffin cells on Renografin gradients. J. Neurosci. Methods. 19, 163-171.
Winkler, H., Sietzen, M., and Schober, M. 1987. The life cycle of catecholamine
-storing vesicles. Ann. NY Acad. Sci. 483, 3-19.
|